Events Archive

Streamlining Legal Workflows Using AI to Enhance Research, Drafting, + Decision Making

Employment-Based Immigration Preference Categories (Fundamentals)

Webinar: Noncompete Update with MMA and Honigman,

"Do you have the right team?"

"Pre-Transitional Planning/What is my After Tax Number?"

"Trump v. United States" - A Discussion With Matthew Schneider

"Honorable Disengagements and Dishonorable Engagements: Reinsurance and Ad Hoc Arbitrations"

"Cutting Edge Conflicts Surrounding the Duty to Defend"

Honigman Legal Academy, Insurance & Licenses Section Presentation

Beneficial Ownership Reporting: The Influence of the Corporate Transparency Act

Credit Unions Buying Community Banks: Motives, Misconceptions, and More on the Horizon – A Conversation with Deal Attorneys Michael Bell and Jeffrey Cardone

Plenary Session: Fraud and Abuse Update

Professional/Management Development Track: Legal Project Management 101: A Case Study

Navigating Gap-Time Claims: Wage and Hour Compliance when Federal Law and State Law Diverge

Innovating with AI in a Legal Context

Value Creation via Human Capital - How Leading Funds are Transforming Portfolio Companies

Disability Law After the Pandemic

Understanding the Tax Division and the Internal Revenue Service

Campaign Finance Compliance

Speaker, Challenging Patents on Reference Drugs: Litigation Strategies for IPR Practice

Office and Industrial

Imposter Syndrome Panel

Independents’ Day: Developments in L, E, and TN Practice

ESG: Investing in your Portfolio

Hospital/Physician Relationships and the Law

Speaker, Latest Trends and Strategic Considerations for Biotech Patent Challenges at the PTAB, Annual PTAB Webinar Series

Moderator, The PTAB Live! Practice, Policy, and Procedure in the New World of Pharmaceutical Patent Challenges, 16th Annual Paragraph IV Disputes

Conference Co-Chair and Speaker, The Hatch-Waxman Landscape: ANDAs, Economics, and Exclusivities, Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA

Moderator, Recent Developments in the Application of Section 112 to Genus Claims

Speaker, Challenging Patents on Reference Drugs: Litigation Strategies in the IPR Forum, 12th Summit on Biosimilars & Innovator Biologics

Canadian Drug Importation: The Rx to Reduce Drug Prices in the U.S.?

No Surprises Act: Federal Legislation Brings Changes (and Many Questions) for Health Plans and Insurers